Maarten P. Bebelman

Maarten P. Bebelman

Auto-generated profile, based on publicly available information

Maarten P. Bebelman

Max Planck Institute of Molecular Cell Biology and Genetics 1 , 01307 Dresden

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Pharmacology & Therapeutics
Verified
Journal Article
Open access
MBMaarten P. Bebelman
Maarten P. Bebelman
MSMartine J. Smit
Martine J. Smit
DPD. Michiel Pegtel
D. Michiel Pegtel
SBS. Rubina Baglio
S. Rubina Baglio
Extracellular vesicles (EVs) are heterogeneous multi-signal messengers that support cancer growth and dissemination by mediating the tumor-stroma crosstalk. Exosomes are a subtype of EVs that originate from the limiting membrane of late endosomes, and as such contain information linked to both the intrinsic cell "state" and the extracellular signals cells received from their environment. Resolving the signals affecting exosome biogenesis, cargo sorting and release will increase our understanding of tumorigenesis. In this review we highlight key cell biological processes that couple exosome biogenesis to cargo sorting in cancer cells. Moreover, we discuss how the bidirectional communication between tumor and non-malignant cells affect cancer growth and metastatic behavior.

16 January 2018 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
FVFrederik Johannes Verweij
Frederik Johannes Verweij
MBMaarten P. Bebelman
Maarten P. Bebelman
CJConnie R. Jimenez
Connie R. Jimenez
JGJuan J. Garcia-Vallejo
Juan J. Garcia-Vallejo
HJHans Janssen
Hans Janssen
DPD. Michiel Pegtel
D. Michiel Pegtel
Exosomes are small endosome-derived extracellular vesicles implicated in cell–cell communication and are secreted by living cells when multivesicular bodies (MVBs) fuse with the plasma membrane (PM). Current techniques to study exosome physiology are based on isolation procedures after secretion, precluding direct and dynamic insight into the mechanics of exosome biogenesis and the regulation of their release. In this study, we propose real-time visualization of MVB–PM fusion to overcome these limitations. We designed tetraspanin-based pH-sensitive optical reporters that detect MVB–PM fusion using live total internal reflection fluorescence and dynamic correlative light–electron microscopy. Quantitative analysis demonstrates that MVB–PM fusion frequency is reduced by depleting the target membrane SNAREs SNAP23 and syntaxin-4 but also can be induced in single cells by stimulation of the histamine H1 receptor (H1HR). Interestingly, activation of H1R1 in HeLa cells increases Ser110 phosphorylation of SNAP23, promoting MVB–PM fusion and the release of CD63-enriched exosomes. Using this single-cell resolution approach, we highlight the modulatory dynamics of MVB exocytosis that will help to increase our understanding of exosome physiology and identify druggable targets in exosome-associated pathologies.

13 December 2019 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
MBMaarten P. Bebelman
Maarten P. Bebelman
PBPhilippe Bun
Philippe Bun
SHStephan Huveneers
Stephan Huveneers
Guillaume Van NielGuillaume Van Niel
Guillaume Van Niel
DPD. Michiel Pegtel
D. Michiel Pegtel
FVFrederik J. Verweij
Frederik J. Verweij

22 September 2022 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
FVFrederik J. Verweij
Frederik J. Verweij
MBMaarten P. Bebelman
Maarten P. Bebelman
AGAnna E. George
Anna E. George
MCMickael Couty
Mickael Couty
ABAnaïs Bécot
Anaïs Bécot
Guillaume Van NielGuillaume Van Niel
Guillaume Van Niel
Exosomes are endosome-derived extracellular vesicles involved in intercellular communication. They are generated as intraluminal vesicles within endosomal compartments that fuse with the plasma membrane (PM). The molecular events that generate secretory endosomes and lead to the release of exosomes are not well understood. We identified a subclass of non-proteolytic endosomes at prelysosomal stage as the compartment of origin of CD63 positive exosomes. These compartments undergo a Rab7a/Arl8b/Rab27a GTPase cascade to fuse with the PM. Dynamic endoplasmic reticulum (ER)-late endosome (LE) membrane contact sites (MCS) through ORP1L have the distinct capacity to modulate this process by affecting LE motility, maturation state, and small GTPase association. Thus, exosome secretion is a multi-step process regulated by GTPase switching and MCS, highlighting the ER as a new player in exosome-mediated intercellular communication.

30 April 2018 in Oncogene
Verified
Journal Article
Open access
PDF file
RHRaimond Heukers
Raimond Heukers
TFTian Shu Fan
Tian Shu Fan
RWRaymond H. de Wit
Raymond H. de Wit
JSJeffrey Roy van Senten
Jeffrey Roy van Senten
Timo De GroofTimo De Groof
Timo De Groof
MSMartine Smit
Martine Smit
Glioblastoma (GBM) is the most aggressive and an incurable type of brain cancer. Human cytomegalovirus (HCMV) DNA and encoded proteins, including the chemokine receptor US28, have been detected in GBM tumors. US28 displays constitutive activity and is able to bind several human chemokines, leading to the activation of various proliferative and inflammatory signaling pathways. Here we show that HCMV, through the expression of US28, significantly enhanced the growth of 3D spheroids of U251− and neurospheres of primary glioblastoma cells. Moreover, US28 expression accelerated the growth of glioblastoma cells in an orthotopic intracranial GBM-model in mice. We developed highly potent and selective US28-targeting nanobodies, which bind to the extracellular domain of US28 and detect US28 in GBM tissue. The nanobodies inhibited chemokine binding and reduced the constitutive US28-mediated signaling with nanomolar potencies and significantly impaired HCMV/US28-mediated tumor growth in vitro and in vivo. This study emphasizes the oncomodulatory role of HCMV-encoded US28 and provides a potential therapeutic approach for HCMV-positive tumors using the nanobody technology.

1 November 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JSJeffrey Roy van Senten
Jeffrey Roy van Senten
MBMaarten P. Bebelman
Maarten P. Bebelman
TFTian Shu Fan
Tian Shu Fan
RHRaimond Heukers
Raimond Heukers
NBNick David Bergkamp
Nick David Bergkamp
MSMartine Smit
Martine Smit
Herpesviruses can rewire cellular signaling in host cells by expressing viral G protein–coupled receptors (GPCRs). These viral receptors exhibit homology to human chemokine receptors, but some display constitutive activity and promiscuous G protein coupling. Human cytomegalovirus (HCMV) has been detected in multiple cancers, including glioblastoma, and its genome encodes four GPCRs. One of these receptors, US28, is expressed in glioblastoma and possesses constitutive activity and oncomodulatory properties. UL33, another HCMV-encoded GPCR, also displays constitutive signaling via Gαq, Gαi, and Gαs proteins. However, little is known about the nature and functional effects of UL33-driven signaling. Here, we assessed UL33's signaling repertoire and oncomodulatory potential. UL33 activated multiple proliferative, angiogenic, and inflammatory signaling pathways in HEK293T and U251 glioblastoma cells. Notably, upon infection, UL33 contributed to HCMV-mediated STAT3 activation. Moreover, UL33 increased spheroid growth in vitro and accelerated tumor growth in different in vivo tumor models, including an orthotopic glioblastoma xenograft model. UL33-mediated signaling was similar to that stimulated by US28; however, UL33-induced tumor growth was delayed. Additionally, the spatiotemporal expression of the two receptors only partially overlapped in HCMV-infected glioblastoma cells. In conclusion, our results unveil that UL33 has broad signaling capacity and provide mechanistic insight into its functional effects. UL33, like US28, exhibits oncomodulatory properties, elicited via constitutive activation of multiple signaling pathways. UL33 and US28 might contribute to HCMV's oncomodulatory effects through complementing and converging cellular signaling, and hence UL33 may represent a promising drug target in HCMV-associated malignancies.